Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 13, 2026 09:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil

COPENHAGEN, Denmark, July 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that its partner, Eurofarma, has submitted a marketing authorization application to the Brazilian Health Regulatory...
July 13, 2026 09:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordics chikungunyavaccine indsendt til myndighedsgodkendelse i Brasilien

KØBENHAVN, Danmark, 13. juli 2026 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabets partner, Eurofarma, har indsendt en ansøgning om markedsføringstilladelse til den brasilianske...
July 13, 2026 03:53 ET | Source: Bavarian Nordic A/S

Bavarian Nordic – Completion of Share Buy-Back Program

COPENHAGEN, Denmark, July 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on June 2, 2026, has now been completed, reaching an...
July 13, 2026 03:53 ET | Source: Bavarian Nordic A/S

Bavarian Nordic – afslutning af aktietilbagekøbsprogram

KØBENHAVN, Danmark, 13. juli 2026 – Bavarian Nordic A/S (OMX: BAVA) meddeler, at aktietilbagekøbsprogrammet, der blev offentliggjort og iværksat den 2. juni 2026, nu er afsluttet, da aktier til et...
July 06, 2026 03:56 ET | Source: Bavarian Nordic A/S

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

COPENHAGEN, Denmark, July 6, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on June 2, 2026, under which the Company will repurchase shares for...
July 06, 2026 03:56 ET | Source: Bavarian Nordic A/S

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

KØBENHAVN, Danmark, 6. juli 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggør transaktioner under aktietilbagekøbsprogrammet, der blev iværksat den 2. juni 2026, hvorunder selskabet vil tilbagekøbe...
June 29, 2026 02:36 ET | Source: Bavarian Nordic A/S

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

COPENHAGEN, Denmark, June 29, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on June 2, 2026, under which the Company will repurchase shares...
June 29, 2026 02:36 ET | Source: Bavarian Nordic A/S

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

KØBENHAVN, Danmark, 29. juni 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggør transaktioner under aktietilbagekøbsprogrammet, der blev iværksat den 2. juni 2026, hvorunder selskabet vil tilbagekøbe...
June 29, 2026 01:30 ET | Source: Bavarian Nordic A/S

Bavarian Nordic Receives Health Canada Approval for Chikungunya Vaccine

COPENHAGEN, Denmark, June 29, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Health Canada has approved VIMKUNYA® (recombinant, adsorbed) for immunization to prevent disease caused by...
June 29, 2026 01:30 ET | Source: Bavarian Nordic A/S

Bavarian Nordics chikungunyavaccine er blevet godkendt af de canadiske lægemiddelmyndigheder

KØBENHAVN, Danmark, 29. juni 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag, at de canadiske lægemiddelmyndigheder, Health Canada, har godkendt VIMKUNYA® (rekombinant, adsorberet) til...